Engineered Microfluidic Tumor Models to Interrogate Cancer Cell Therapy Resistance Mechanisms
Time: 11:30 am
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 2 AM
Details:
- Examining critical gaps in the translational development of cell therapies that limit their efficacy in the clinic
- Exploring engineered platforms to study cell therapy activity in diverse patient samples
- Elucidating the mechanisms that limit cell therapy activity can enable researchers to ‘fail fast’ and improve candidate selection
